マラリアの治療と予防策
JAMA
|November 17, 1978
まとめ
医師は,マラリアを治療し,旅行用薬を用意する準備を整えなければならない. クロロクインは,ほとんどのマラリア症例に推奨されますが,キニンは,耐性菌株に対する完璧な予防策がなく,重度のPlasmodium falciparum感染症に好ましいです.
科学分野:
- 医学科学 医学科学 医学科学 医学科学
- 感染症 感染症は感染症です.
- トロピカル・メディシン (熱帯医学)
背景:
- マラリアは,特に旅行者にとって,世界的な健康上の大きな懸念事項であり続けています.
- 医師は,マラリアの治療と予防に関する最新のガイドラインを必要としています.
研究 の 目的:
- マラリアの予防と治療に関する現在の推奨事項を概説する.
- 特定のマラリア株の管理における課題を強調する.
主な方法:
- マラリアの確立された治療ガイドラインのレビュー.
- 異なるプラズモジア種と感染の重症度に対する薬剤の有効性の分析.
主要な成果:
- クロロクイン塩化水素は,軽度のマラリアと一般的な予防のための主要な薬剤です.
- キニンは,重度のPlasmodium falciparum感染症の好ましい治療法である.
- プラズモディアム・ビバックスとプラズモディアム・オヴァールにはプリマキンが必要であり,グルコース-6-リン酸脱水原酶の検査が必要である.
- 米国では,クロロクインに耐性のあるPlasmodium falciparumに対する完全に効果的な予防法は存在しない.
結論:
- 医師は,マラリアの治療と予防に備えなければならない.
- 現在の推奨は,クロロキンとキニンを好み,プリマキンと耐性菌株については特に考慮しています.
関連する概念動画
00:58Symbiosis
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:28Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...